Cargando…

Peripheral Blood Immune Cell Composition After Autologous MSC Infusion in Kidney Transplantation Recipients

Tacrolimus is the backbone of immunosuppressive agents to prevent transplant rejection. Paradoxically, tacrolimus is nephrotoxic, causing irreversible tubulointerstitial damage. Therefore, infusion of mesenchymal stromal cells (MSC) 6 and 7 weeks post-transplantation was assessed to facilitate withd...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendriks, Sanne H., Heidt, Sebastiaan, Schulz, Axel R., de Fijter, Johan W., Reinders, Marlies E. J., Koning, Frits, van Kooten, Cees
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Health Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326287/ https://www.ncbi.nlm.nih.gov/pubmed/37426430 http://dx.doi.org/10.3389/ti.2023.11329

Ejemplares similares

Cell-free DNA measurement of three genomes after allogeneic MSC therapy in kidney transplant recipients indicates early cell death of infused MSC
por: Dreyer, Geertje J., et al.
Publicado: (2023)

Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients
por: Reinders, Marlies EJ, et al.
Publicado: (2014)

Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study
por: Reinders, Marlies E. J., et al.
Publicado: (2015)

Autologous bone marrow‐derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single‐center, open‐label TRITON study
por: Reinders, Marlies E. J., et al.
Publicado: (2021)

Cardiovascular Effects of Autologous Bone Marrow–Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study
por: Meucci, Maria Chiara, et al.
Publicado: (2021)

Relinquishing Anonymity in Living Donor Kidney Transplantation: Lessons Learned From the UK Policy for Anonymous Donors
por: Pronk, Mathilde C., et al.
Publicado: (2022)

A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry
por: Bezstarosti, Suzanne, et al.
Publicado: (2022)

Immune Profiling of Peripheral Blood Mononuclear Cells at Pancreas Acute Rejection Episodes in Kidney-Pancreas Transplant Recipients
por: Rovira, Jordi, et al.
Publicado: (2022)

NK Cells and MSCs: Possible Implications for MSC Therapy in Renal Transplantation
por: Reinders, Marlies EJ, et al.
Publicado: (2014)

Chronic Pancreas Allograft Rejection Followed by Successful HLA-Incompatible Islet Alloautotransplantation: A Novel Strategy?
por: Veltkamp, Denise M. J., et al.
Publicado: (2023)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

Heart Transplantation in High-Risk Recipients Employing Donor Marginal Grafts Preserved With Ex-Vivo Perfusion
por: Sponga, Sandro, et al.
Publicado: (2023)

Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients
por: Morath, Christian, et al.
Publicado: (2022)

Matching Donor and Recipient Size in Pediatric Heart Transplantation
por: Singh, Tajinder P., et al.
Publicado: (2022)

Hearing Impairments as an Overlooked Condition in Kidney Transplant Recipients
por: Simsir, Melis, et al.
Publicado: (2022)

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Circulating Long Noncoding RNA LNC-EPHA6 Associates with Acute Rejection after Kidney Transplantation
por: Groeneweg, Koen E., et al.
Publicado: (2020)

Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single‐center study
por: Dreyer, Geertje J., et al.
Publicado: (2020)

A Kidney Transplant Recipient on Prophylactic Eculizumab Presenting With Myalgia
por: Shivakumar, Oshini, et al.
Publicado: (2022)

Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
por: Hilbrands, Luuk, et al.
Publicado: (2022)

Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients
por: Cheng, Rui-Juan, et al.
Publicado: (2019)

Treatment With Diflunisal in Domino Liver Transplant Recipients With Acquired Amyloid Neuropathy
por: Nedkova-Hristova, Velina, et al.
Publicado: (2022)

MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction
por: Miyahara, Naofumi, et al.
Publicado: (2022)

Urological Complications Associated With Pyeloureterostomy Without Ipsilateral Nephrectomy in Renal Transplant Recipients
por: Neto, Hernani M., et al.
Publicado: (2022)

Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish Cohort
por: Dos Santos, Quenia, et al.
Publicado: (2022)

Impact of Size Matching Based on Donor-Recipient Height on Kidney Transplant Outcomes
por: Tandukar, Srijan, et al.
Publicado: (2022)

Normothermic Machine Perfusion—Improving the Supply of Transplantable Livers for High-Risk Recipients
por: Hann, Angus, et al.
Publicado: (2022)

Combined Donor-Recipient Obesity and the Risk of Graft Loss After Kidney Transplantation
por: Jarrar, Faisal, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination-Induced Immunogenicity in Heart Transplant Recipients
por: Memenga, Felix, et al.
Publicado: (2023)

Predictors and Adverse Outcomes of Acute Kidney Injury in Hospitalized Renal Transplant Recipients
por: Hod, Tammy, et al.
Publicado: (2023)

When There is No Guidance From the Guidelines: Renal Transplantation in Recipients With Class III Obesity
por: Gillespie, Hannah, et al.
Publicado: (2023)

Increasing Kidney-Exchange Options Within the Existing Living Donor Pool With CIAT: A Pilot Implementation Study
por: de Klerk, Marry, et al.
Publicado: (2023)

Long-Term Kidney and Maternal Outcomes After Pregnancy in Living Kidney Donors
por: van Buren, Marleen C., et al.
Publicado: (2023)

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection
por: van Vugt, Lukas K., et al.
Publicado: (2023)

Donor-Transmitted Cancer in Orthotopic Solid Organ Transplant Recipients: A Systematic Review
por: Greenhall, George H. B., et al.
Publicado: (2022)

Abatacept Rescue Therapy in Kidney Transplant Recipients: A Case Series of Five Patients
por: Uro-Coste, Charlotte, et al.
Publicado: (2022)

Individual-Level Socioeconomic Position and Long-Term Prognosis in Danish Heart-Transplant Recipients
por: Mols, Rikke E., et al.
Publicado: (2023)

Tremor, Daily Functioning, and Health-Related Quality of Life in Solid Organ Transplant Recipients
por: Riemersma, Niels L., et al.
Publicado: (2023)

Telehealth Experience Among Liver and Kidney Transplant Recipients: A Mixed Methods Study
por: Ko, Dami, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dobm99c8v5b7nvspbvlqmpeb8j